Journal article
The therapeutic potential of GLP-1 analogues for stress-related eating and role of GLP-1 in stress, emotion and mood: a review
E Guerrero-Hreins, AP Goldstone, RM Brown, P Sumithran
Progress in Neuro Psychopharmacology and Biological Psychiatry | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2021
Abstract
Stress and low mood are powerful triggers for compulsive overeating, a maladaptive form of eating leading to negative physical and mental health consequences. Stress-vulnerable individuals, such as people with obesity, are particularly prone to overconsumption of high energy foods and may use it as a coping mechanism for general life stressors. Recent advances in the treatment of obesity and related co-morbidities have focused on the therapeutic potential of anorexigenic gut hormones, such as glucagon-like peptide 1 (GLP-1), which acts both peripherally and centrally to reduce energy intake. Besides its appetite suppressing effect, GLP-1 acts on areas of the brain involved in stress response..
View full abstractGrants
Awarded by UK Research and Innovation
Funding Acknowledgements
EGH is supported by a Melbourne Research Scholarship. APG is supported by UK Medical Research Council Experimental Medicine Grant (MR/M007022/1). RMB is supported by ARC DECRA (DE190101244). PS is supported by a National Health and Medical Research Council Investigator Grant (1178482).